Dilated cardiomyopathy due to a phospholamban duplication

Area of Science:

• Genetics
• Cardiology
• Developmental Biology

Background:

• Dilated cardiomyopathy (DCM) is a condition affecting heart muscle, leading to impaired function.
• Genetic factors are increasingly recognized as a cause of pediatric DCM.
• Complex cytogenetic abnormalities can manifest with multisystemic effects.

Observation:

• A pediatric case presented with dilated cardiomyopathy, failure to thrive, and developmental delay.
• The patient exhibited a 624 kb duplication at 6q22.31, encompassing the phospholamban gene.
• Additional complex chromosomal abnormalities were identified: a 5p15 deletion (Cri du Chat syndrome) and an 11p15 duplication (Russell-Silver syndrome).

Findings:

• A specific duplication of 6q22.31, including the phospholamban gene, was identified as the cause of dilated cardiomyopathy in this child.
• The co-occurrence of 5p15 deletion and 11p15 duplication contributed to the patient's developmental delay and failure to thrive.
• This case highlights the intricate relationship between specific genetic duplications/deletions and complex pediatric phenotypes.

Implications:

• Identifying the phospholamban gene duplication provides a specific genetic diagnosis for pediatric dilated cardiomyopathy.
• Understanding these complex cytogenetic abnormalities aids in predicting and managing multisystemic developmental issues.
• This case underscores the importance of comprehensive genetic analysis in children with unexplained cardiomyopathy and developmental disorders.